Miracle Mile Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.96M | Buy |
10,939
+324
| +3% | +$111K | 0.05% | 241 |
|
|
2026
Q1 | $3.73M | Buy |
10,615
+154
| +1% | +$54.9K | 0.05% | 225 |
|
|
2025
Q4 | $3.42M | Sell |
10,461
-216
| -2% | -$68.5K | 0.05% | 234 |
|
|
2025
Q3 | $3.01M | Sell |
10,677
-6,677
| -38% | -$1.94M | 0.05% | 243 |
|
|
2025
Q2 | $4.85M | Buy |
17,354
+8,563
| +97% | +$2.43M | 0.08% | 160 |
|
|
2025
Q1 | $2.74M | Buy |
8,791
+2,775
| +46% | +$819K | 0.05% | 188 |
|
|
2024
Q4 | $1.57M | Buy |
6,016
+176
| +3% | +$52.2K | 0.03% | 260 |
|
|
2024
Q3 | $1.88M | Buy |
5,840
+672
| +13% | +$220K | 0.04% | 199 |
|
|
2024
Q2 | $1.61M | Buy |
5,168
+254
| +5% | +$74.6K | 0.04% | 205 |
|
|
2024
Q1 | $1.4M | Buy |
4,914
+303
| +7% | +$88.7K | 0.04% | 222 |
|
|
2023
Q4 | $1.33M | Buy |
4,611
+1,264
| +38% | +$344K | 0.04% | 214 |
|
|
2023
Q3 | $900K | Sell |
3,347
-7
| -0.2% | -$1.75K | 0.03% | 264 |
|
|
2023
Q2 | $745K | Buy |
3,354
+275
| +9% | +$63.8K | 0.02% | 295 |
|
|
2023
Q1 | $744K | Sell |
3,079
-95
| -3% | -$23.3K | 0.02% | 315 |
|
|
2022
Q4 | $834K | Buy |
3,174
+80
| +3% | +$21.4K | 0.03% | 296 |
|
|
2022
Q3 | $697K | Sell |
3,094
-36
| -1% | -$8.73K | 0.03% | 245 |
|
|
2022
Q2 | $761K | Buy |
3,130
+2,016
| +181% | +$494K | 0.04% | 250 |
|
|
2022
Q1 | $270K | Sell |
1,114
-109
| -9% | -$25K | 0.01% | 404 |
|
|
2021
Q4 | $275K | Sell |
1,223
-1,894
| -61% | -$400K | 0.01% | 383 |
|
|
2021
Q3 | $663K | Buy |
3,117
+2,040
| +189% | +$470K | 0.03% | 254 |
|
|
2021
Q2 | $262K | Buy |
1,077
+41
| +4% | +$10.1K | 0.01% | 333 |
|
|
2021
Q1 | $258K | Sell |
1,036
-2,140
| -67% | -$511K | 0.01% | 329 |
|
|
2020
Q4 | $730K | Buy |
3,176
+2,332
| +276% | +$538K | 0.04% | 227 |
|
|
2020
Q3 | $215K | Buy |
+844
| New | +$209K | 0.02% | 324 |
|
|
2020
Q2 | – | Sell |
-1,045
| Closed | -$212K | – | 306 |
|
|
2020
Q1 | $212K | Sell |
1,045
-816
| -44% | -$178K | 0.02% | 254 |
|
|
2019
Q4 | $449K | Buy |
1,861
+614
| +49% | +$135K | 0.03% | 203 |
|
|
2019
Q3 | $241K | Sell |
1,247
-781
| -39% | -$150K | 0.02% | 251 |
|
|
2019
Q2 | $374K | Buy |
2,028
+28
| +1% | +$5.01K | 0.03% | 202 |
|
|
2019
Q1 | $380K | Buy |
2,000
+8
| +0.4% | +$1.53K | 0.03% | 202 |
|
|
2018
Q4 | $388K | Buy |
1,992
+50
| +3% | +$9.76K | 0.05% | 103 |
|
|
2018
Q3 | $403K | Hold |
1,942
| – | – | 0.04% | 128 |
|
|
2018
Q2 | $358K | Buy |
1,942
+125
| +7% | +$22.1K | 0.03% | 125 |
|
|
2018
Q1 | $310K | Sell |
1,817
-20
| -1% | -$3.67K | 0.03% | 126 |
|
|
2017
Q4 | $319K | Sell |
1,837
-95
| -5% | -$16.8K | 0.05% | 78 |
|
|
2017
Q3 | $360K | Buy |
1,932
+678
| +54% | +$120K | 0.06% | 57 |
|
|
2017
Q2 | $216K | Sell |
1,254
-2,013
| -62% | -$327K | 0.04% | 63 |
|
|
2017
Q1 | $536K | Buy |
+3,267
| New | +$543K | 0.1% | 48 |
|
|
2016
Q4 | – | Sell |
-1,519
| Closed | -$253K | – | 88 |
|
|
2016
Q3 | $253K | Buy |
1,519
+10
| +0.7% | +$1.69K | 0.06% | 68 |
|
|
2016
Q2 | $246K | Buy |
+1,509
| New | +$235K | 0.08% | 52 |
|
|
2015
Q2 | – | Sell |
-2,091
| Closed | -$329K | – | 38 |
|
|
2015
Q1 | $329K | Sell |
2,091
-50
| -2% | -$7.88K | 0.35% | 19 |
|
|
2014
Q4 | $341K | Hold |
2,141
| – | – | 0.37% | 20 |
|
|
2014
Q3 | $301K | Buy |
2,141
+138
| +7% | +$18K | 0.38% | 16 |
|
|
2014
Q2 | $229K | Hold |
2,003
| – | – | 0.41% | 10 |
|
|
2014
Q1 | $229K | Hold |
2,003
| – | – | 0.45% | 8 |
|
|
2013
Q4 | $229K | Buy |
+2,003
| New | +$228K | 1.88% | 4 |
|
Other funds holding AMGN
Miracle Mile Advisors's AMGN Position: Q2 2026 in Review
Miracle Mile Advisors increased its Amgen (AMGN) stake by 3.1% in Q2 2026, buying an estimated $111K and bringing the position to 10,939 shares worth $3.96M. The position accounts for 0.05% of the portfolio, ranked #241.
Miracle Mile Advisors first reported a position in AMGN in Q4 2013 and has held it in 45 quarters since. The position peaked at $4.85M in Q2 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Miracle Mile Advisors held 10,939 shares of Amgen worth $3.96M as of Q2 2026.
- Miracle Mile Advisors bought 324 Amgen shares in Q2 2026, an estimated $111K.
- Amgen made up 0.05% of Miracle Mile Advisors's portfolio in Q2 2026, its #241 holding.
- Miracle Mile Advisors first reported a position in Amgen in Q4 2013 and has held it in 45 quarters since.
- Miracle Mile Advisors's Amgen position peaked at $4.85M in Q2 2025.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.